HomeAI · summaries
Storia in 2 fonti
Thousands with type 2 diabetes could swap daily injections for weekly jab
Jump to contentAllNewsSportCultureLifestyleHundreds of thousands of people with type 2 diabetes could benefit from a new weekly jab that reduces required annual insulin injections by 86 per cent. The National Institute for Health and Care Excellence (Nice) has recommended insulin efsitora alfa, also known as Onswik, in final draft guidance. Manufactured by Eli Lilly, the weekly treatment is shown to work as well as daily injections, cutting annual doses from 365 to 52. Health experts said the jab will offer greater freedom and particularly benefit frail patients, those with sight loss and people relying on carers. The treatment must now be approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) before it can be rolled out on the NHS. In fullNew type 2 diabetes jab could cut number of injections by 86 per centMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
New type 2 diabetes jab could cut number of injections by 86 per cent
The treatment, also known as Onswik and made by Eli Lilly, is said to work as well as daily injections
- ·
Thousands with type 2 diabetes could swap daily injections for weekly jab
Jump to contentAllNewsSportCultureLifestyleHundreds of thousands of people with type 2 diabetes could benefit from a new weekly jab that reduces required annual insulin injections…
